China Biologic Products Holdings Overview

China Biologic Products Holdings Operating Income

Operating Income for CBPO.

Quarterly Operating Income

$32.64M

↑ 75.52% YoY

As of Dec 31, 2020

Annual Operating Income (TTM)

$193.58M

↑ 18.29% YoY

Trailing 12 months ending Dec 31, 2020

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin